1-5 of 5
Jong-Youl Jin
Close
Sort by
Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Kihyun Kim, Seok Jin Kim, MD, PhD, Byung Soo Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Hye Jin Kang, MD, Jin Seok Kim, M.D., Ph.D., Yeung-Chul Mun, Chul Soo Kim, MD, Sang Kyun Sohn, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, Hyeok Shim, Hwi-Joong Yoon, Jong-Youl Jin, Chang-Ki Min, MD, Ho Jin Shin, Hyun Chun Shin, Jong-Ho Won, Je-Jung Lee, MD, PhD, Jung Hye Kwon, Young-Don Joo, MD, PhD, Young Rok Do, M.D., Sung Hyun Kim, Sukjoong Oh, MD, Cheolwon Suh, MD, Junglim Lee, Sung-Soo Yoon, Min Kyoung Kim, Soo-Mee Bang, Hun-Mo Ryoo, Bong-Seog Kim, Hawk Kim, MD, Hyo-Jung Kim, Yang Soo Kim, Chong Won Park, Gyeong-Won Lee, Seongkyu Park, Joon Seong Park, MD, Ho Young Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2009) 114 (22): 4881.
https://doi.org/10.1182/blood.V114.22.4881.4881
Published: 2009
Journal Articles

Velcade ® , Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial

HyeonSeok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, Kihyun Kim, Hyo-Jung Kim, HoYoung Kim, Jong-Youl Jin, Young-Rok Do, Suk-Joong Oh, Cheolwon Suh, Chu-Myong Seong, Chul Soo Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2008) 112 (11): 2785.
https://doi.org/10.1182/blood.V112.11.2785.2785
Published: 2008
Journal Articles

Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population?

Youngil Koh, Soo-Mee Bang, MD, PhD, Jae Hoon Lee, Hwi-Joong Yoon, Young-Rok Do, PhD, Hun-Mo Ryoo, Nari Lee, Seok Jin Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Yeung-Chul Mun, MD, PhD, Moon-Hee Lee, Jong-Youl Jin, MD, PhD, Hyo-Jung Kim, HyeonSeok Eom, MD, PhD, Min Kyoung Kim, MD, Hyun Chun Shin, Korean Multiple Myeloma Working Party
Journal: Blood
Blood (2008) 112 (11): 5146.
https://doi.org/10.1182/blood.V112.11.5146.5146
Published: 2008
Journal Articles

Bortezomib, Doxorubicin and Dexamethasone (PAD) Combination Therapy Followed by Thalidomide and Dexamethasone (TD) as a Salvage Treatment for Relapsed Multiple Myeloma (MM): Preliminary Analysis of Efficacy and Safety.

Sung Sook Lee, Cheolwon Suh, Bong-Seog Kim, Jooseop Chung, Young-Don Joo, Hun-Mo Ryoo, Young Rok Do, Jong-Youl Jin, Hye Jin Kang, Gyeong-Won Lee, Moon Hee Lee, Hyeok Shim, Kihyun Kim, Sung-Soo Yoon, Ho Young Kim, Dong Soon Lee, Jae-Hoon Lee
Journal: Blood
Blood (2007) 110 (11): 2731.
https://doi.org/10.1182/blood.V110.11.2731.2731
Published: 2007
Journal Articles

Optimal TBI Dose to Improve the Survival in Unrelated Matched Marrow Transplantation for Adult Patients with Severe Aplastic Anemia: Prospective De-Escalation Study of TBI Dose.

Jong-Wook Lee, MD, Ki Seong Eom, MD, Yoon Hee Park, MD, Yoo Jin Kim, MD, Seok Lee, MD, Chang Ki Min, MD, Hee Je Kim, MD, Dong Wook Kim, MD, Jong Youl Jin, MD, Woo Sung Min, MD, Chong Won Park, MD, Chun Choo Kim, MD
Journal: Blood
Blood (2004) 104 (11): 2770.
https://doi.org/10.1182/blood.V104.11.2770.2770
Published: 2004